ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
1,2,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
2,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
2,2,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
2,3,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
2,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
3,1,Gamma-glutamyltransferase increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
3,2,Hypoaesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,1,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
4,2,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
4,3,Influenza like illness,General signs and symptoms NEC,General system disorders NEC,Genrl,N
4,4,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
4,5,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
5,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
6,1,Diarrhoea,Diarrhoea (excl infective),Gastrointestinal motility and defaecation conditions,Gastr,N
6,2,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
6,3,Palmar erythema,Erythemas,Epidermal and dermal conditions,Skin,N
7,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
7,2,Chromaturia,Urinary abnormalities,Urinary tract signs and symptoms,Renal,N
7,3,Faeces pale,Faecal abnormalities NEC,Gastrointestinal signs and symptoms,Gastr,N
7,4,Hepatitis,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
7,5,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
7,6,Pruritus,Pruritus NEC,Epidermal and dermal conditions,Skin,N
8,1,Renal failure,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
9,1,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
10,1,Decreased appetite,Appetite disorders,Appetite and general nutritional disorders,Metab,N
10,2,Hepatitis acute,Hepatocellular damage and hepatitis NEC,Hepatic and hepatobiliary disorders,Hepat,N
10,3,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
10,4,Liver function test abnormal,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
11,2,Blood pressure increased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
11,3,Confusional state,Confusion and disorientation,Deliria (incl confusion),Psych,N
11,4,Constipation,Gastrointestinal atonic and hypomotility disorders NEC,Gastrointestinal motility and defaecation conditions,Gastr,N
11,5,Heart rate increased,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
11,6,Liver function test increased,Hepatobiliary function diagnostic procedures,Hepatobiliary investigations,Inv,N
11,7,Muscular weakness,Muscle weakness conditions,Muscle disorders,Musc,N
11,8,Neurological symptom,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
11,9,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
11,10,Urinary retention,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
11,11,Weight bearing difficulty,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
12,1,Jaundice,Cholestasis and jaundice,Hepatic and hepatobiliary disorders,Hepat,N
13,1,Ketoacidosis,Metabolic acidoses (excl diabetic acidoses),Acid-base disorders,Metab,N
14,1,Blister,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,2,Dermatitis bullous,Bullous conditions,Epidermal and dermal conditions,Skin,N
14,3,Drug reaction with eosinophilia and systemic symptoms,Dermatitis ascribed to specific agent,Epidermal and dermal conditions,Skin,N
14,4,Hypertransaminasaemia,Hepatic enzymes and function abnormalities,Hepatic and hepatobiliary disorders,Hepat,N
14,5,Inflammation,Inflammations,General system disorders NEC,Genrl,N
14,6,Malaise,Asthenic conditions,General system disorders NEC,Genrl,N
14,7,Rash morbilliform,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,8,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
15,1,Amnesia,Memory loss (excl dementia),Mental impairment disorders,Nerv,N
15,2,Dizziness,Neurological signs and symptoms NEC,Neurological disorders NEC,Nerv,N
15,3,Fall,Non-site specific injuries NEC,Injuries NEC,Inj&P,N
15,4,Renal pain,Urinary tract signs and symptoms NEC,Urinary tract signs and symptoms,Renal,N
16,1,Acute kidney injury,Renal failure and impairment,Renal disorders (excl nephropathies),Renal,N
16,2,Acute myocardial infarction,Ischaemic coronary artery disorders,Coronary artery disorders,Card,N
16,3,Atrioventricular block,Cardiac conduction disorders,Cardiac arrhythmias,Card,N
16,4,Off label use,Off label uses,Off label uses and intentional product misuses/use issues,Inj&P,N
17,1,Abdominal distension,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
17,2,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
17,3,Abnormal loss of weight,General nutritional disorders NEC,Appetite and general nutritional disorders,Metab,N
17,4,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,5,Bladder pain,Bladder and urethral symptoms,Urinary tract signs and symptoms,Renal,N
17,6,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,7,Condition aggravated,General signs and symptoms NEC,General system disorders NEC,Genrl,N
17,8,Drug tolerance decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
17,9,Flank pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,10,Flatulence,"Flatulence, bloating and distension",Gastrointestinal signs and symptoms,Gastr,N
17,11,Myalgia,Muscle pains,Muscle disorders,Musc,N
17,12,Neuralgia,Sensory abnormalities NEC,Neurological disorders NEC,Nerv,N
17,13,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
17,14,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
17,15,Product contamination,Product contamination and sterility issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
17,16,Product label issue,Product label issues,"Product quality, supply, distribution, manufacturing and quality system issues",Prod,N
17,17,Visceral pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
